Heidy King-Jones
General Counsel, Axcella Health (United States).
Companies
- Aeglea BioTherapeuticsOfficer Sep 5, 2023 to now1
- Provention Bio, Inc.General counsel Aug 3, 2020 to Apr 27, 20232
- Axcella Health (United States)General counsel Nov 25, 2019 to Dec 20, 20193
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Aeglea BioTherapeutics SYRE2,845 shares4$243.4K at $85.57Sep 2, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Sep 2, 2026Sold 400 shares at $90.00 of Aeglea BioTherapeutics4
- Sep 2, 2026Exercised options 400 shares at $14.50 of Aeglea BioTherapeutics4
- Sep 1, 2026Sold 400 shares at $89.38 of Aeglea BioTherapeutics4
- Sep 1, 2026Sold 6,206 shares at $88.17 of Aeglea BioTherapeutics4
- Sep 1, 2026Sold 16,548 shares at $87.20 of Aeglea BioTherapeutics4
- Sep 1, 2026Sold 4,845 shares at $86.40 of Aeglea BioTherapeutics4
- Sep 1, 2026Exercised options 27,999 shares at $14.50 of Aeglea BioTherapeutics4
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARAeglea BioTherapeutics, Officer
- 2
- 3
- 4